Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHSRN peptide eye drops for intractable corneal epithelial disorders
jRCTs061180037Recruiting
- Start
- Mar 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of PHSRN peptide in Corneal epithelial defect and corneal persistent epithelial defect (PED). Primary endpoints: Change in corneal epithelial disorder and Time to complete healing of persistent epithelial defect. Started Mar 2009; status: recruiting.
02
Drugs
PHSRN peptide
03
Conditions
Corneal epithelial defectcorneal persistent epithelial defect (PED)
Beyond the preview
Go deeper on jRCTs061180037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061180037.